Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an error screen. The prior study details and related sections are no longer visible.SummaryDifference16%

- Check21 days agoChange DetectedThe study page adds a site in Coeur d'Alene, Idaho, and updates multiple data-collection time windows (e.g., post-dose follow-ups for safety and efficacy, progression assessments, and patient-reported outcomes). These changes reflect revised conduct details for the trial and affect how and over what period outcomes are measured.SummaryDifference0.3%

- Check35 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new version of the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now reflects a newer software revision tag (v3.6.5) by replacing the previous v3.6.4. This indicates a minor backend update rather than a visible change to the study details or user-facing information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now displays a newer revision label (v3.6.4) replacing the prior v3.6.3, indicating an updated version of the page/document. This change reflects a version update rather than a substantive alteration to the study content.SummaryDifference0.0%

- Check93 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3. This indicates a newer version of the page, likely a minor update or bug fix rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.